首页> 美国卫生研究院文献>Current Oncology >A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis
【2h】

A Critical Appraisal of Evidence- and Consensus-Based Guidelines for Actinic Keratosis

机译:基于证据和共识的神光角膜病指南的批判性评估

代理获取
本网站仅为用户提供外文OA文献查询和代理获取服务,本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文,但由于OA文献来源多样且变更频繁,仍可能出现获取不到、文献不完整或与标题不符等情况,如果获取不到我们将提供退款服务。请知悉。

摘要

Actinic keratoses (AK) are common lesions of the skin that can be effectively treated with several lesion- and field-directed treatments. Clinical practice guidelines assist physicians in choosing the appropriate treatment options for their patients. Here, we aimed to systematically identify and evaluate the methodological quality of currently available guidelines for AK. Guidelines published within the last 5 years were identified in a systematic search of guideline databases, Medline and Embase. Then, six independent reviewers evaluated the methodological quality using the tools “Appraisal of Guidelines for Research and Evaluation” (AGREE II) and “Recommendation EXcellence” (AGREE-REX). The Kruskal–Wallis (H) test was used to explore differences among subgroups and Spearman’s correlation to examine the relationship between individual domains. Three guidelines developed by consortia from Canada, Germany and the United Kingdom were eligible for the evaluation. The German guideline achieved the highest scores, fulfilling 65 to 92% of the criteria in AGREE II and 67 to 84% in AGREE-REX, whereas the Canadian guideline scored 31 to 71% of the criteria in AGREE II and 33 to 46% in AGREE-REX. The domains “stakeholder involvement“ and “values and preferences“ were identified as methodological weaknesses requiring particular attention and improvement in future guideline efforts.
机译:活体角膜(AK)是皮肤的常见病变,可以用几个病变和田间治疗有效处理。临床实践指南有助于医生为其患者选择合适的治疗方案。在这里,我们旨在系统地识别和评估目前AK目前可用指南的方法论质量。在过去5年内发布的指南在制定指南数据库,MEDLINE和EMBASE的系统搜索中确定。然后,六名独立审查员使用“研究和评估准则”(同意II)和“卓越建议”(同意REX)的工具评估了方法论质量。 Kruskal-Wallis(H)测试用于探讨亚组和Spearman之间的差异,以检查个别域之间的关系。来自加拿大,德国和英国的联盟开发的三个指导方针有资格获得评估。德国指南取得了最高分,达到了65%至92%的标准,同意II和67%至84%,而加拿大指南达到31%至71%的标准,同意II和33%至46%同意雷克斯。域名“利益相关者参与”和“价值和偏好”被确定为需要特别注意和未来指南努力的特殊关注和改善的方法论弱点。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
代理获取

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号